Rebecca B. Delconte

1.9k total citations · 1 hit paper
22 papers, 887 citations indexed

About

Rebecca B. Delconte is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Rebecca B. Delconte has authored 22 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in Rebecca B. Delconte's work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (11 papers) and Immune cells in cancer (6 papers). Rebecca B. Delconte is often cited by papers focused on Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (11 papers) and Immune cells in cancer (6 papers). Rebecca B. Delconte collaborates with scholars based in Australia, United States and France. Rebecca B. Delconte's co-authors include Joseph C. Sun, Adriana M. Mujal, Nicholas D. Huntington, Fernando Souza-Fonseca-Guimarães, Jai Rautela, Éric Vivier, Andreas Strasser, Andrew M. Lew, Ingela B. Vikstrom and Sandra E. Nicholson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Rebecca B. Delconte

21 papers receiving 881 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

2023 138 citations Jing Hu, Francisco J. Sánchez‐Rivera et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebecca B. Delconte Australia	13	639	327	241	90	48	22	887
Ane Orrantia Spain	14	570 0.9×	284 0.9×	180 0.7×	115 1.3×	63 1.3×	24	811
Luna Minute Spain	12	529 0.8×	504 1.5×	194 0.8×	60 0.7×	41 0.9×	16	858
Florent Carrette France	11	510 0.8×	259 0.8×	318 1.3×	62 0.7×	43 0.9×	16	853
Hyung‐seung Jin South Korea	16	529 0.8×	346 1.1×	448 1.9×	132 1.5×	25 0.5×	27	943
Ganapathy Sriram United States	13	342 0.5×	185 0.6×	280 1.2×	55 0.6×	35 0.7×	19	679
Ariel Raybuck United States	10	460 0.7×	160 0.5×	336 1.4×	259 2.9×	30 0.6×	16	832
Bhalchandra Mirlekar United States	11	643 1.0×	458 1.4×	278 1.2×	94 1.0×	10 0.2×	15	973
Céline Colacios France	14	525 0.8×	493 1.5×	309 1.3×	88 1.0×	16 0.3×	25	1.0k
James J. Ignatz-Hoover United States	12	251 0.4×	273 0.8×	379 1.6×	81 0.9×	124 2.6×	25	749

Countries citing papers authored by Rebecca B. Delconte

Since Specialization

Citations

This map shows the geographic impact of Rebecca B. Delconte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca B. Delconte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca B. Delconte more than expected).

Fields of papers citing papers by Rebecca B. Delconte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca B. Delconte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca B. Delconte. The network helps show where Rebecca B. Delconte may publish in the future.

Co-authorship network of co-authors of Rebecca B. Delconte

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca B. Delconte. A scholar is included among the top collaborators of Rebecca B. Delconte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca B. Delconte. Rebecca B. Delconte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santosa, Endi K., et al.. (2025). TCF19 drives a broad transcriptional program that potentiates optimal innate and adaptive functions of antiviral NK cells. Nature Immunology. 26(9). 1467–1475.

Sheppard, Sam, Katja Srpan, Rebecca B. Delconte, et al.. (2024). Fatty acid oxidation fuels natural killer cell responses against infection and cancer. Proceedings of the National Academy of Sciences. 121(11). e2319254121–e2319254121. 30 indexed citations

Delconte, Rebecca B. & Joseph C. Sun. (2024). Metabolic programming of organ‐specific natural killer cell responses. Immunological Reviews. 323(1). 8–18. 4 indexed citations

Delconte, Rebecca B., Mark Owyong, Endi K. Santosa, et al.. (2024). Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity. Immunity. 57(8). 1923–1938.e7. 23 indexed citations

Hu, Jing, Francisco J. Sánchez‐Rivera, Zhenghan Wang, et al.. (2023). STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature. 616(7958). 806–813. 138 indexed citations breakdown →

Delconte, Rebecca B., et al.. (2023). Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunity. Current Opinion in Immunology. 84. 102364–102364. 9 indexed citations

Bernard, P, Rebecca B. Delconte, Sonia Pastor, et al.. (2022). Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. Journal for ImmunoTherapy of Cancer. 10(5). e004244–e004244. 48 indexed citations

Mujal, Adriana M., Rebecca B. Delconte, & Joseph C. Sun. (2021). Natural Killer Cells: From Innate to Adaptive Features. Annual Review of Immunology. 39(1). 417–447. 125 indexed citations

Scheer, Sebastian, Jacob T. Jackson, Soroor Hediyeh-zadeh, et al.. (2020). Hhex Directly Represses BIM-Dependent Apoptosis to Promote NK Cell Development and Maintenance. Cell Reports. 33(3). 108285–108285. 8 indexed citations

10.

Delconte, Rebecca B., Geoffrey Guittard, Soroor Hediyeh-zadeh, et al.. (2020). NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CIS. Frontiers in Immunology. 11. 75–75. 30 indexed citations

11.

Hennessy, Robert J., Kim Pham, Rebecca B. Delconte, et al.. (2019). Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions. Journal of Leukocyte Biology. 105(6). 1341–1354. 12 indexed citations

12.

Rautela, Jai, Laura F. Dagley, Carolina Camargo de Oliveira, et al.. (2019). Therapeutic blockade of activin-A improves NK cell function and antitumor immunity. Science Signaling. 12(596). 68 indexed citations

13.

Rautela, Jai, Laura F. Dagley, Tobias Kratina, et al.. (2018). Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cells. Molecular Immunology. 115. 56–63. 2 indexed citations

14.

Sun, Li, Jai Rautela, Rebecca B. Delconte, et al.. (2018). GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function. Frontiers in Immunology. 9. 1922–1922. 32 indexed citations

15.

Jiao, Yuhao, Joanne E. Davis, Jai Rautela, et al.. (2018). Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes. Cell Death and Differentiation. 26(8). 1516–1530. 10 indexed citations

16.

Putz, Eva Maria, Camille Guillerey, Kevin Kos, et al.. (2017). Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis. OncoImmunology. 6(2). e1267892–e1267892. 48 indexed citations

17.

Sathe, Priyanka, Swee Heng Milon Pang, Rebecca B. Delconte, Ngaire Elwood, & Nicholas D. Huntington. (2017). Identification of Novel Human NK Cell Progenitor Subsets. International Journal of Molecular Sciences. 18(12). 2716–2716. 4 indexed citations

18.

Carrington, Emma M., Yifan Zhan, Jamie L. Brady, et al.. (2017). Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death and Differentiation. 24(5). 878–888. 116 indexed citations

19.

Delconte, Rebecca B., Nicholas D. Huntington, David M. Tarlinton, et al.. (2016). Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. The Journal of Immunology. 197(5). 2000–2008. 21 indexed citations

20.

Sathe, Priyanka, Rebecca B. Delconte, Fernando Souza-Fonseca-Guimarães, et al.. (2014). Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells. Nature Communications. 5(1). 4539–4539. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact